Xian‐Da Yang
Impact in
- Drug Discovery top 5%
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 17
- Nanoparticle-Based Drug Delivery 17
-
- Immunotherapy and Immune Responses 7
- Co-authors
- Jinhong Duan (18 shared papers)Haiyan Xu (7 shared papers)Yan Hu (8 shared papers)Jie Meng (4 shared papers)Xin Lu (4 shared papers)Chen Wang (4 shared papers)Fengdan Wang (2 shared papers)Xundou Li (11 shared papers)
- Journals
- PLoS ONE (5 papers)Molecules (4 papers)Scientific Reports (3 papers)Cancer Nanotechnology (3 papers)Oncotarget (2 papers)
- Partner nations
- China
In The Last Decade
Xian‐Da Yang
30 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 61
- Drug Discovery 15
- Biomaterials 552
- Molecular Biology 599
- Immunology 126
- Biomedical Engineering 236
Countries citing papers authored by Xian‐Da Yang
This map shows the geographic impact of Xian‐Da Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xian‐Da Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xian‐Da Yang more than expected).
Fields of papers citing papers by Xian‐Da Yang
This network shows the impact of papers produced by Xian‐Da Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xian‐Da Yang. The network helps show where Xian‐Da Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xian‐Da Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 210 | |
| 2 | 2011 | 172 | |
| 3 | 2012 | 167 | |
| 4 | 2012 | 137 | |
| 5 | 2008 | 115 | |
| 6 | 2016 | 71 | |
| 7 | 2020 | 62 | |
| 8 | 2011 | 44 | |
| 9 | 2010 | 38 | |
| 10 | 2009 | 35 | |
| 11 | 2020 | 34 | |
| 12 | 2013 | 31 | |
| 13 | 2019 | 29 | |
| 14 | 2014 | 26 | |
| 15 | 2014 | 25 | |
| 16 | 2010 | 20 | |
| 17 | 2021 | 19 | |
| 18 | 2023 | 19 | |
| 19 | 2016 | 17 | |
| 20 | 2019 | 17 |
About Xian‐Da Yang
Xian‐Da Yang is a scholar working on Biomaterials, Immunology, Molecular Biology, Oncology and Biomedical Engineering, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (17 papers), Advanced biosensing and bioanalysis techniques (10 papers), RNA Interference and Gene Delivery (9 papers), Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (1 paper), Nitric Oxide and Endothelin Effects (1 paper) and Graphene and Nanomaterials Applications (1 paper). The work is most often cited by research in Drug Discovery (15 citations), Biomaterials (552 citations), Molecular Biology (599 citations), Immunology (126 citations) and Biomedical Engineering (236 citations). Xian‐Da Yang has collaborated with scholars based in China. Frequent co-authors include Jinhong Duan, Haiyan Xu, Yan Hu, Jie Meng, Xin Lu, Chen Wang, Fengdan Wang, Xundou Li, Wei Ping Liang and Chen Wang. Their work appears in journals such as PLoS ONE, Molecules, Scientific Reports, Cancer Nanotechnology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.